Gold JS, Antonescu CR, Hajdu C, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002;94(4):1057–68.

Article  PubMed  Google Scholar 

Demicco EG, Fritchie KJ, Han A. Solitary Fibrous Tumour.Classification of Tumours Editorial Board. IARC; 2020.

Google Scholar 

de Pinieux G, Karanian M, Le Loarer F, et al. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS ONE. 2021;16(2):e0246958.

Article  PubMed  PubMed Central  Google Scholar 

Klemperer P, Coleman BR. Primary neoplasms of the pleura. A report of five cases. Am J Ind Med. 1992;22(1):1–31.

Article  CAS  PubMed  Google Scholar 

Gronchi A, Miceli R, Allard MA, et al. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol. 2015;22(5):1447–54.

Article  PubMed  Google Scholar 

Vallat-Decouvelaere AV, Dry SM, Fletcher CD. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 1998;22(12):1501–11.

Article  CAS  PubMed  Google Scholar 

Cranshaw IM, Gikas PD, Fisher C, Thway K, Thomas JM, Hayes AJ. Clinical outcomes of extra-thoracic solitary fibrous tumours. Eur J Surg Oncol. 2009;35(9):994–8.

Article  CAS  PubMed  Google Scholar 

Lottin M, Escande A, Bauchet L et al. Intracranial solitary fibrous tumour management: A French multicentre retrospective study. Cancers Basel. 2023;15(3).

de Bernardi A, Dufresne A, Mishellany F, Blay JY, Ray-Coquard I, Brahmi M. Novel therapeutic options for solitary fibrous tumor: Antiangiogenic therapy and beyond. Cancers Basel. 2022;14(4):1064.

Article  PubMed  PubMed Central  Google Scholar 

Salas S, Resseguier N, Blay JY, et al. Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol. 2017;28(8):1979–87.

Article  CAS  PubMed  Google Scholar 

Outani H, Kobayashi E, Wasa J, et al. Clinical outcomes of patients with metastatic solitary fibrous tumors: A Japanese musculoskeletal oncology group (JMOG) multiinstitutional study. Ann Surg Oncol. 2021;28(7):3893–901.

Article  PubMed  Google Scholar 

Ronchi A, Cozzolino I, Zito Marino F, et al. Extrapleural solitary fibrous tumor: a distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features. Ann Diagn Pathol. 2018;34:142–50.

Article  PubMed  Google Scholar 

Gholami S, Cassidy MR, Kirane A, et al. Size and location are the most important risk factors for malignant behavior in resected solitary fibrous tumors. Ann Surg Oncol. 2017;24(13):3865–71.

Article  PubMed  Google Scholar 

Champeaux Depond C, Zouaoui S, Darlix A, et al. Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006-2015. Acta Neurochir Wien. 2024;166(1):320.

Article  PubMed  Google Scholar 

El-Abtah ME, Murayi R, Ejikeme T, et al. A single-center retrospective analysis of intracranial and spinal solitary fibrous tumor/hemangiopericytoma clinical outcomes: Sex association with aggressiveness. World Neurosurg. 2023;169:e190–6.

Article  PubMed  Google Scholar 

Schweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013;125(5):651–8.

Article  CAS  PubMed  Google Scholar 

Robinson DR, Wu YM, Kalyana-Sundaram S, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013;45(2):180–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chmielecki J, Crago AM, Rosenberg M, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013;45(2):131–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohajeri A, Tayebwa J, Collin A, et al. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer. 2013;52(10):873–86.

Article  CAS  PubMed  Google Scholar 

Demicco EG, Wani K, Fox PS, et al. Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations. Hum Pathol. 2015;46(7):1015–26.

Article  CAS  PubMed  Google Scholar 

Stacchiotti S, Negri T, Palassini E, et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. Mol Cancer Ther. 2010;9(5):1286–97.

Article  CAS  PubMed  Google Scholar 

Hajdu M, Singer S, Maki RG, Schwartz GK, Keohan ML, Antonescu CR. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. J Pathol. 2010;221(3):300–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji RC. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. Cancer Lett. 2014;346(1):6–16.

Article  CAS  PubMed  Google Scholar 

Hatva E, Böhling T, Jääskeläinen J, Persico MG, Haltia M, Alitalo K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol. 1996;148(3):763–75.

CAS  PubMed  PubMed Central  Google Scholar 

Bahrami A, Lee S, Schaefer IM, et al. TERT promoter mutations and prognosis in solitary fibrous tumor. Mod Pathol. 2016;29(12):1511-1522.

Vogels R, Macagno N, Griewank K, et al. Prognostic significance of NAB2-STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear. Acta Neuropathol. 2019;137(4):679–82.

Article  PubMed  Google Scholar 

Akaike K, Kurisaki-Arakawa A, Hara K, et al. Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential. Hum Pathol. 2015;46(3):347–56.

Article  CAS  PubMed  Google Scholar 

Kurisaki-Arakawa A, Akaike K, Hara K, et al. A case of dedifferentiated solitary fibrous tumor in the pelvis with TP53 mutation. Virchows Arch. 2014;465(5):615–21.

Article  CAS  PubMed  Google Scholar 

Martin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N. A comprehensive review on solitary fibrous tumor: new insights for New Horizons. Cancers Basel. 2021;13(12):2913.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fletcher C, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Editorial Board: IARC; 2013.

Google Scholar 

Demicco EG, Fritchie KJ, Han A. WHO Classification of Tumors, Soft Tissue and Bone Tumours. IARC; 2020.

Google Scholar 

Mosquera JM, Fletcher CDM. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component–is this dedifferentiated SFT? Am J Surg Pathol. 2009;33(9):1314–21.

Article  PubMed  Google Scholar 

Olson NJ, Linos K. Dedifferentiated solitary fibrous tumor: a concise review. Arch Pathol Lab Med. 2018;142(6):761–6.

Article  CAS  PubMed  Google Scholar 

Demicco EG, Park MS, Araujo DM, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25(9):1298–306.

Article  PubMed  Google Scholar 

Reisenauer JS, Mneimneh W, Jenkins S, et al. Comparison of risk stratification models to predict recurrence and survival in pleuropulmonary solitary fibrous tumor. J Thorac Oncol. 2018;13(9):1349–62.

Article